Sun Pharmaceutical Industries Ltd. Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd.
SEARCH
Go
Formulation Sun Pharmaceutical Industries Ltd.
API Sun Pharmaceutical Industries Ltd.
Field Force Sun Pharmaceutical Industries Ltd.
Earmings Call Transcript Q3 FY08
Sun Pharma Q3 FY08 Financials
Sun Pharma reports strong performance,Q3 FY08 Sales growth 49%, Profit Increased 60%, R&D spend at Rs 842 million
Q2 2007-08 Conference Call Readout
More...
Sun Pharmaceutical announces launch of generic Ethyol® (180 days exclusivity)
Sun Pharmaceutical announces USFDA approval to market generic Tessalon®
More...
No. 1 in India in speciality therapy areas like
psychiatry, neurology, cardiology, among the
top 3 companies in a total of 7 therapy areas
Brands in 30 markets worldwide
Successful US generic presence with Caraco Pharm Labs, Sun Pharmaceutical Industries Inc (subsidiary)
Annual Reports Sirius
SITE MAP    DISCLAIMER    PRIVACY POLICY    INTRANET    FIELD FORCE
Copyright © Sun Pharmaceutical Industries Ltd.
Developed by Aqua Info Media
(Optimised for IE 5.0 and 1024* 768 resolution and above.)